In December of last year, the federal court judge overseeing the MDL relating to Zantac claims effectively dismissed all cases against GSK. This was most certainly the worst news possible, but can Zantac claims possibly make a comeback? Potentially yes, with a few serious caveats. Even though Judge Rosenberg’s ruling on the admissibility of expert […]
A Comeback for Zantac? Read More »
By Ken Hardison Artificial Intelligence (AI) has become one of the hottest topics taking the business world by storm. This cutting edged technology has tremendous application for today’s law firms. Unlike the Metaverse, which garnered significant initial interest but has yet to deliver appreciable results, AI is already a potential game changer for users who
What Does Artificial Intelligence Mean for you and your Law Firm’s Growth? Read More »
By W. Cameron Stephenson, Esq. Levin Papantonio Rafferty JOHNSON & JOHNSON’S ATTEMPT TO AVOID TALC LIABILITY THROUGH ABUSE OF U.S. BANKRUPTCY CODE DID NOT WORK Global giant Johnson & Johnson concentrates its business in pharmaceutical, medical device, and consumer packaged goods. In 2021 alone, the company generated approximately $93.7 billion in revenue. As of this
Corporate Boardrooms Listen Up Read More »
